by Brad N. Taylor, Ph.D. | Mar 9, 2023
CBM, Nucleus Biologics, and Stoic Bio have launched a collaborative partnership to expedite the sustainable development of CGT therapies. The Center for Breakthrough Medicine (CBM) is a contract development and manufacturing organization (CDMO) located within The...
by Brad N. Taylor, Ph.D. | Mar 7, 2023
San Diego, CA, March 7, 2023 – In a joint effort to accelerate high-quality therapies to market, Nucleus Biologics, The Cell Performance Company™, a leading provider of custom cell culture media solutions for the cell and gene therapy industry, and Stoic Bio, a...
by Brad N. Taylor, Ph.D. | Oct 18, 2022
New state-of-the-art cleanrooms will be the centerpiece of the already thriving small business, as the company seeks to expand their GMP-compliant manufacturing capabilities. Nucleus Biologics’ newly expanded facility is officially open for business! A festive...
by Brad N. Taylor, Ph.D. | Sep 23, 2022
(San Diego, CA – September 23, 2022) — Nucleus Biologics, The Cell Performance Company™, an industry-leading provider of small lot custom cell culture media, celebrated the opening of its newest building on their San Diego campus and the unveiling of additional...
by Brad N. Taylor, Ph.D. | Aug 23, 2022
ISO 13485:2016 certification demonstrates Nucleus Biologics’ commitment to maintaining premium quality standards. (San Diego, CA – August 23, 2022) Nucleus Biologics, The Cell Performance Company™, the industry-leading provider of small lot custom media for the cell...
by Brad N. Taylor, Ph.D. | Feb 28, 2022
Krakatoa’s point of use media manufacturing reduces greenhouse gas emissions by 65% per unit of media produced. (San Diego, CA – February 28, 2022) Nucleus Biologics, The Cell Performance Company™, is proud to announce the launch of Krakatoa™, an innovative,...
